Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices 53175 

1450; by fax marked to her attention at 

(571) 273–7755; or by email to 

Mary.Till@uspto.gov. 

SUPPLEMENTARY INFORMATION: Section 

156 of Title 35, United States Code, 

generally provides that the term of a 

patent may be extended for a period of 

up to five years if the patent claims a 

product, or a method of making or using 

a product, that has been subject to 

certain defined regulatory review, and 

that the patent may be extended for 

interim periods of up to one year if the 

regulatory review is anticipated to 

extend beyond the expiration date of the 

patent. 

On May 13, 2014, Bracco Suisse SA, 

the patent owner of record, timely filed 

an application under 35 U.S.C. 

§ 156(d)(5) for an interim extension of 

the term of U.S. Patent No. 5,686,060. 

The patent claims the human drug 

product LUMASONTM, sulfur 

hexafluoride microbubbles. The 

application indicates that Bracco 

Diagnostics Inc., an affiliate of patent 

owner Bracco Suisse SA, initially 

submitted a New Drug Application 

(NDA) #21–315 to the Food and Drug 

Administration (FDA) on January 21, 

2001, and withdrew NDA #21–315 on 

December 20, 2007. Bracco Diagnostics 

Inc. submitted a new NDA #203–684 on 

December 20, 2011. FDA accepted NDA 

203–684 for filing on February 19, 2012. 

Review of the application indicates 

that, except for permission to market or 

use the product commercially, the 

subject patent would be eligible for an 

extension of the patent term under 35 

U.S.C. 156, and that the patent should 

be extended for one year as required by 

35 U.S.C. 156(d)(5)(B). Because the 

regulatory review period will continue 

beyond the original expiration date of 

the patent, November 11, 2014, interim 

extension of the patent term under 35 

U.S.C. 156(d)(5) is appropriate. 

An interim extension under 35 U.S.C. 

156(d)(5) of the term of U.S. Patent No. 

5,686,060 is granted for a period of one 

year from the original expiration date of 

the patent. 

Dated: August 26, 2014. 

Andrew Hirshfeld. 

Deputy Commissioner for Patent Examination 

Policy, United States Patent and Trademark 

Office. 

[FR Doc. 2014–21308 Filed 9–5–14; 8:45 am] 

BILLING CODE 3510–16–P 

COMMODITY FUTURES TRADING 

COMMISSION 

Sunshine Act Meetings 

TIME AND DATE: 10:30 a.m., Thursday, 

September 11, 2014. 

PLACE: 1155 21st St. NW., Washington, 

DC, 9th Floor Commission Conference 

Room. 

STATUS: Closed. 

MATTERS TO BE CONSIDERED: 

Surveillance, Enforcement Matters, and 

Examinations. In the event that the 

times, dates, or locations of this or any 

future meetings change, an 

announcement of the change, along with 

the new time and place of the meeting 

will be posted on the Commission’s 

Web site at http://www.cftc.gov. 

CONTACT PERSON FOR MORE INFORMATION: 

Christopher J. Kirkpatrick, 202–418– 

5964. 

Christopher J. Kirkpatrick, 

Secretary of the Commission. 

[FR Doc. 2014–21400 Filed 9–4–14; 4:15 pm] 

BILLING CODE 6351–01–P 

DEPARTMENT OF DEFENSE 

Department of the Army 

Army Education Advisory Committee 

Meeting Notice 

AGENCY: Department of the Army, DoD. 

ACTION: Notice of open committee 

meeting. 

SUMMARY: The Department of the Army 

is publishing this notice to announce 

the following Federal advisory 

committee meeting of the Army 

Education Advisory Committee. This 

meeting is open to the public. 

DATES: The Army Education Advisory 

Committee will meet from 8:00 a.m. to 

5:00 p.m. on October 8 and 9, 2014 and 

from 8:00 a.m. to 2:00 p.m. on October 

10, 2014. 

ADDRESSES: Army Education Advisory 

Committee, U.S. Training Doctrine 

Command, Building 950, Conference 

Room 2014, Fort Eustis, VA 23604. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Wayne Joyner, the Designated Federal 

Officer for the committee, in writing at 

ATTN: ATTG–ZC, U.S. Training 

Doctrine Command, 950 Jefferson Ave, 

Fort Eustis, VA 23604, by email at 

albert.w.joyner.civ@mail.mil, or by 

telephone at (757) 501–5810. 

SUPPLEMENTARY INFORMATION: The 

committee meeting is being held under 

the provisions of the Federal Advisory 

Committee Act of 1972 (5 U.S.C., 

Appendix, as amended), the 

Government in the Sunshine Act of 

1976 (5 U.S.C. 552b, as amended), and 

41 CFR 102–3.150. 

Purpose of the Meeting: The purpose 

of the meeting is to collect and analyze 

corporate and academia best practices 

for dealing with sexual harassment and 

assault. 

Proposed Agenda: October 8–9: The 

committee is chartered to provide 

independent advice and 

recommendations to the Secretary of the 

Army on the educational, doctrinal, and 

research policies and activities of U.S. 

Army educational programs. The 

committee will review and evaluate 

information related to dealing with 

sexual harassment and assault, and 

explore cultural issues affecting sexual 

harassment and assault. The committee 

will discuss societal norms, generational 

differences, changes in cultural 

dynamics, and sexual attitudes that may 

impact the Army’s culture. 

Public Accessibility to the Meeting: 

Pursuant to 5 U.S.C. 552b, as amended, 

and 41 CFR 102–3.140 through 102– 

3.165, and subject to the availability of 

space, this meeting is open to the 

public. Seating is on a first to arrive 

basis. Attendees are requested to submit 

their name, affiliation, and daytime 

phone number seven business days 

prior to the meeting to Mr. Joyner, via 

electronic mail, the preferred mode of 

submission, at the address listed in the 

FOR FURTHER INFORMATION CONTACT

section. 

Because the meeting of the committee 

will be held in a Federal Government 

facility on a military base, security 

screening is required. A photo ID is 

required to enter base. Please note that 

security and gate guards have the right 

to inspect vehicles and persons seeking 

to enter and exit the installation. U.S. 

Training Doctrine Command is fully 

handicap accessible. Wheelchair access 

is available in front at the main entrance 

of the building. For additional 

information about public access 

procedures, contact Mr. Joyner, the 

committee’s Designated Federal Officer, 

at the email address or telephone 

number listed in the FOR FURTHER

INFORMATION CONTACT section. 

Written Comments or Statements: 

Pursuant to 41 CFR 102–3.105(j) and 

102–3.140 and section 10(a)(3) of the 

Federal Advisory Committee Act, the 

public or interested organizations may 

submit written comments or statements 

to the committee, in response to the 

stated agenda of the open meeting or in 

regard to the committee’s mission in 

general. Written comments or 

statements should be submitted to Mr. 

Joyner the committee Designated 


rmajette on DSK2TPTVN1PROD with NOTICES